The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.

PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...

- Results showed 100% sensitivity and reduced time to diagnosis by an estimated 65.5%, with potential to improve pathologists’ workflow in a real-world environment -Brazil-based Grupo Oncoclinicas is ...

Ventana Medical Systems, Inc. (Ventana) has unveiled the latest versions of its Virtuoso digital pathology image and workflow management software and VANTAGE workflow solution for histology lab ...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology software, has launched its first product that assists digital pathology labs across research, ...

LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory revenue cycle management (lab RCM) solutions, and PathPresenter, a global leader ...

Technical Session on Generative AI: "Towards an AI Co-Pathologist," 28 June at 1pm in the Auditorium. Speaker: Dr. Rajendra Singh. Integrations of AI models from industry leading vendors. "Exhibiting ...

AISight® is a cloud-native, intelligent enterprise workflow solution designed to help laboratories streamline pathology workflows, enhance case assignment and image management, and integrate ...

At this year's 29th Congress of the International Academy of Pathology (IAP 2012), Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, will unveil the latest versions of its Virtuoso ...